225 related articles for article (PubMed ID: 7713879)
21. Differential prenyl pyrophosphate binding to mammalian protein geranylgeranyltransferase-I and protein farnesyltransferase and its consequence on the specificity of protein prenylation.
Yokoyama K; Zimmerman K; Scholten J; Gelb MH
J Biol Chem; 1997 Feb; 272(7):3944-52. PubMed ID: 9020098
[TBL] [Abstract][Full Text] [Related]
22. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity.
Lebowitz PF; Davide JP; Prendergast GC
Mol Cell Biol; 1995 Dec; 15(12):6613-22. PubMed ID: 8524226
[TBL] [Abstract][Full Text] [Related]
23. A non-peptide mimetic of Ras-CAAX: selective inhibition of farnesyltransferase and Ras processing.
Vogt A; Qian Y; Blaskovich MA; Fossum RD; Hamilton AD; Sebti SM
J Biol Chem; 1995 Jan; 270(2):660-4. PubMed ID: 7822292
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I.
Zhang FL; Kirschmeier P; Carr D; James L; Bond RW; Wang L; Patton R; Windsor WT; Syto R; Zhang R; Bishop WR
J Biol Chem; 1997 Apr; 272(15):10232-9. PubMed ID: 9092572
[TBL] [Abstract][Full Text] [Related]
25. Rab geranylgeranyl transferase catalyzes the geranylgeranylation of adjacent cysteines in the small GTPases Rab1A, Rab3A, and Rab5A.
Farnsworth CC; Seabra MC; Ericsson LH; Gelb MH; Glomset JA
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):11963-7. PubMed ID: 7991565
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic modification of proteins with a geranylgeranyl isoprenoid.
Casey PJ; Thissen JA; Moomaw JF
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8631-5. PubMed ID: 1924324
[TBL] [Abstract][Full Text] [Related]
27. [Protein farnesyl and geranylgeranyl transferases].
de Gunzburg J
C R Seances Soc Biol Fil; 1991; 185(5):290-305. PubMed ID: 1806188
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the interaction of the monomeric GTP-binding protein Rab3a with geranylgeranyl transferase II.
Johannes L; Perez F; Laran-Chich MP; Henry JP; Darchen F
Eur J Biochem; 1996 Jul; 239(2):362-8. PubMed ID: 8706741
[TBL] [Abstract][Full Text] [Related]
29. A protein geranylgeranyltransferase from bovine brain: implications for protein prenylation specificity.
Yokoyama K; Goodwin GW; Ghomashchi F; Glomset JA; Gelb MH
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5302-6. PubMed ID: 2052607
[TBL] [Abstract][Full Text] [Related]
30. Bet2p and Mad2p are components of a prenyltransferase that adds geranylgeranyl onto Ypt1p and Sec4p.
Jiang Y; Rossi G; Ferro-Novick S
Nature; 1993 Nov; 366(6450):84-6. PubMed ID: 8232542
[TBL] [Abstract][Full Text] [Related]
31. Dominant negative alpha-subunit of farnesyl- and geranylgeranyl-transferase I inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes.
Solomon CS; Leitner JW; Goalstone ML
Int J Obes Relat Metab Disord; 2003 Jan; 27(1):40-7. PubMed ID: 12532152
[TBL] [Abstract][Full Text] [Related]
32. Properties of Rab5 N-terminal domain dictate prenylation of C-terminal cysteines.
Sanford JC; Pan Y; Wessling-Resnick M
Mol Biol Cell; 1995 Jan; 6(1):71-85. PubMed ID: 7749197
[TBL] [Abstract][Full Text] [Related]
33. Nifedipine prevents etoposide-induced caspase-3 activation, prenyl transferase degradation and loss in cell viability in pancreatic β-cells.
Arora DK; Mohammed AM; Kowluru A
Apoptosis; 2013 Jan; 18(1):1-8. PubMed ID: 23054080
[TBL] [Abstract][Full Text] [Related]
34. Amino acid substitutions that convert the protein substrate specificity of farnesyltransferase to that of geranylgeranyltransferase type I.
Del Villar K; Mitsuzawa H; Yang W; Sattler I; Tamanoi F
J Biol Chem; 1997 Jan; 272(1):680-7. PubMed ID: 8995312
[TBL] [Abstract][Full Text] [Related]
35. Protein prenylation in an insect cell-free protein synthesis system and identification of products by mass spectrometry.
Suzuki T; Ito M; Ezure T; Shikata M; Ando E; Utsumi T; Tsunasawa S; Nishimura O
Proteomics; 2007 Jun; 7(12):1942-50. PubMed ID: 17514686
[TBL] [Abstract][Full Text] [Related]
36. Mammalian protein geranylgeranyltransferase-I: substrate specificity, kinetic mechanism, metal requirements, and affinity labeling.
Yokoyama K; McGeady P; Gelb MH
Biochemistry; 1995 Jan; 34(4):1344-54. PubMed ID: 7827082
[TBL] [Abstract][Full Text] [Related]
37. In vitro identification of a soluble protein:geranylgeranyl transferase from rat tissues.
Joly A; Popják G; Edwards PA
J Biol Chem; 1991 Jul; 266(21):13495-8. PubMed ID: 1906876
[TBL] [Abstract][Full Text] [Related]
38. Protein Geranylgeranyltransferase Type 1 as a Target in Cancer.
Ullah N; Mansha M; Casey PJ
Curr Cancer Drug Targets; 2016; 16(7):563-71. PubMed ID: 26648485
[TBL] [Abstract][Full Text] [Related]
39. Enzymic characterization of fission yeast farnesyl transferase: recognition of the -CAAL motif at the C-terminus.
Danjoh I; Fujiyama A
Eur J Biochem; 1996 Mar; 236(3):847-51. PubMed ID: 8665904
[TBL] [Abstract][Full Text] [Related]
40. Protein Farnesyltransferase Catalyzes Unanticipated Farnesylation and Geranylgeranylation of Shortened Target Sequences.
Ashok S; Hildebrandt ER; Ruiz CS; Hardgrove DS; Coreno DW; Schmidt WK; Hougland JL
Biochemistry; 2020 Mar; 59(11):1149-1162. PubMed ID: 32125828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
